Results 101 to 110 of about 376,311 (300)

New combined hepatitis A and B vaccine [PDF]

, 1997
Martin Dedicoat, Christopher J. Ellis
openalex   +1 more source

A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.

Journal of Infectious Diseases, 2016
Brenna C. Simons, P. Spradling, D. Bruden, C. Zanis, S. Case, T. Choromanski, Minjun C. Apodaca, Hazel D Brogdon, Gaelen K. Dwyer, Mary M Snowball, S. Negus, M. Bruce, C. Morishima, C. Knall, B. McMahon   +14 more
semanticscholar   +1 more source

Vaccination in Multiple Myeloma: Challenges and Strategies

European Journal of Haematology, EarlyView.
ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy characterized by profound immunosuppression resulting from both disease‐related mechanisms and treatment‐induced immune dysfunction. This compromised immune status markedly increases susceptibility to infections, a leading cause of morbidity and mortality in MM patients.
Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Santino Caserta, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Hepatitis B vaccine prepared from HBeAg positive plasma.

, 1987
Takao Ohmura, Yutaka Hirao, Haruhide Kawabe, Yahiro Uemura, Masayuki Nishida   +4 more
openalex   +2 more sources

Immunogenicity of low-dose plasma-derived hepatitis B vaccine [PDF]

, 1997
Mark Kane, Julie B. Milstien
openalex   +1 more source

Evaluating inclusiveness and diversity in health misinformation correction research: A scoping review

Health Information &Libraries Journal, EarlyView.
Abstract Background The inclusion of marginalized populations in health information research is crucial for ensuring equitable health outcomes and addressing systemic disparities. However, underrepresentation of these groups remains a significant issue, particularly in health misinformation correction research.
Romy RW, Junhan Chen, Yuan Wang
wiley   +1 more source

The Costa Rican Experience on the Serological Response to the Hepatitis B Vaccine in Health Professionals [PDF]

, 1999
María Aparicio Ruiz, Wilbert Alfaro-Bourrouet, Idis Faingezicht   +2 more
openalex   +1 more source

Long-term Protection After Hepatitis B Vaccine.

Journal of Infectious Diseases, 2016
Pierre Van Damme
semanticscholar   +1 more source

Morbidity and risk factors of COVID‐19 in people with HIV‐1 in Europe: A combined observational cohort and nested case–control study

HIV Medicine, EarlyView.
Abstract Objective To study the COVID‐19 disease course in people living with HIV (PLWH) based on meaningful case numbers, information about comorbidities, antiretroviral and COVID‐19 treatment and HIV disease‐related variables. Methods Multi‐centre, observational, retrospective study of people living with HIV with COVID‐19 matched to HIV‐uninfected ...
Georg M. N. Behrens, Lambert Assoumou, Stephane De Wit, Rona MacDonald, Nathalie de Castro, Casper Rokx, Holly Middleditch, Margaret Johnson, Jose Luis Casado, Jose Ramon Arribas, Jose‐Ramon Blanco, Carl Fletcher, Caroline Eteve‐Pitsaer, Aliou Baldé, Anton Pozniak, Esteban Martinez, on behalf of the HIV CoCo Study Group, Arkaitz Imaz, David Rial Crestelo, Mar Masia Canuto, Jose Luis Blanco Arevalo, Alberto Díaz De Santiago, Pere Domingo Pedrol, Patrick Philibert, Jean‐Michel Molina, Frank Post, Ade Apoola, Chloe Orkin, Mark Gompels, Margherita Bracchi, Julie Fox, Marta Vasylyev   +31 more
wiley   +1 more source

Seroconversion of hepatitis B vaccine among patients from outpatient clinic in Georgia. [PDF]

Vaccine X, 2023
Kanchelashvili G, Kamkamidze G, Davitadze M, Bzishvili N, Abzianidze T, Gulbiani L, Butsashvili M.   +6 more
europepmc   +1 more source